Catalyst Wire Dossier Catalyst Wire Dossier

AMJEVITA

adalimumab-atto · Nuvaila Limited
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for AMJEVITA, covering 2016-09-23 to 2025-10-16. Get the full timeline:

Most recent: FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)

See pricing